Our findings that c-FLIP and CD95 are important key regulators in survival of ccRCC cells might be used for new therapeutic approaches to overcome apoptosis resistance in RCC by downregulating their expression. The gene discussed is FAS; the disease is nonpapillary renal cell carcinoma.